Breaking News, Collaborations & Alliances

Batavia, Chromatan Receive NIIMBL Grant to Improve AAV Manufacturing

To integrate column-free continuous chromatography into HIP-Vax manufacturing platform.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Batavia Biosciences, a contract development and manufacturing organization, has partnered with ChromaTan, Inc. for the development and integration of BioRMB (formerly known as Continuous Countercurrent Tangential Chromatography or CCTC) technology into Batavia’s AAV HIP-Vax manufacturing platform. The project aims to improve AAV manufacturing and reduce manufacturing costs through process intensification.   Recombinant adeno-associated virus (rAAV) vectors are spearheading the development of n...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters